Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.

Men could soon be offered quick MRI scans lasting under 15 minutes to detect prostate cancer earlier, under new ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

RadNet (RDNT) reports record Q4 2025 revenue of $547.7M, up 14.8%, with Digital Health surging 48% and strong 2026 guidance driven by AI growth.

Lord Brady discovered he had the disease after taking a PSA blood test that indicates cancer risk. This was followed by two ...

Full-body MRIs are all the rage. Celebrities and influencers tout the benefits of such scans that could find asymptomatic aneurysms and cancers lurking in your body. Sometimes, they're life-saving.

The drug makes prostate cancer easier to detect and stage because it attaches to the cancer cells themselves. This marks the third PSMA‑targeted radiopharmaceutical manufactured at Huntsman Cancer ...